Skip to main content
Biosenta Inc. logo

Biosenta Inc. — Investor Relations & Filings

Ticker · ZRO ISIN · CA09072N2023 CSE Manufacturing
Open in API
Filings indexed 316 across all filing types
Latest filing 2026-03-02 Regulatory Filings
Country CA Canada
Listing CSE ZRO

About Biosenta Inc.

https://www.biosenta.com

Biosenta Inc. develops, manufactures, and sells innovative, eco-friendly antimicrobial chemical compounds utilizing encapsulated nanotechnology. The company specializes in producing state-of-the-art solutions designed to eliminate harmful microorganisms for household and industrial applications. Biosenta's product portfolio includes Tri-Filler, a revolutionary anti-microbial filler used in soft and hard textiles. The company focuses on setting new global standards by delivering effective cleaning and material solutions that prioritize human and environmental safety.

Recent filings

Filing Released Lang Actions
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2026-03-02 English
Interim MD&A - English.pdf
Regulatory Filings
2026-03-02 English
Interim financial statements/report – English.pdf
Regulatory Filings
2026-03-02 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Audit Report / Information Classification · 95% confidence The document is a 'Form 52-109FV1', which is a Venture Issuer Basic Certificate required under Canadian securities legislation to accompany annual filings. It serves as a formal certification by the CEO regarding the accuracy and fair presentation of the company's annual financial statements and MD&A. Since it is a regulatory certification document that does not fit into the primary financial reporting categories (like 10-K or IR) and is not an announcement of a report, it falls under the 'Regulatory Filings' category. FY 2025
2026-01-28 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Audit Report / Information Classification · 95% confidence The document is a 'Form 52-109FV1', which is a Venture Issuer Basic Certificate used in Canadian securities regulation to certify annual filings. It is a standalone regulatory certification document signed by the CFO, confirming the accuracy of the annual financial statements and MD&A. Since it is a specific regulatory certification document rather than the annual report itself, and it does not fit into the other specific categories like 10-K or AR, it is best classified as a Regulatory Filing. FY 2025
2026-01-28 English
Annual MD&A - English.pdf
Management Reports Classification · 100% confidence The document is explicitly titled 'Management’s Discussion & Analysis' (MD&A) for the year ended September 30, 2025. It provides a detailed review of the company's business, strategy, intellectual property, and financial performance, which is the standard content for an MD&A report. While it references annual financial statements, the document itself is the management's narrative analysis of those results, fitting the definition of the MDA category.
2026-01-28 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.